
	Mr. James H. Welch, also known as Jim, served as the Chief Financial Officer of AcelRx Pharmaceuticals, Inc. from October 1, 2010 to March 2014 and served as its Principal Accounting Officer until March 2014. Mr. Welch served as the Chief Financial Officer of Cerimon Pharmaceuticals, Inc. He is responsible for financial and legal divisions and manages relationships with investors and the broader financial community. He serves as the Director of Human Resources at Guardian Industries Corp. He has over two decades&#39; experience in financial management of life science and technology firms. He served as the Chief Financial Officer, President and Secretary of Rigel Pharmaceuticals Inc. since October 2001 and served as its Principal Accounting Officer. Mr. Welch joined Rigel Pharmaceuticals Inc. as Vice President of Finance, Corporate Services and Administration and Assistant Secretary in May 1999. During his tenure at Rigel, he completed several financing vehicles, including Cerimon Pharmaceuticals, Inc.&#39;s IPO in late 2000. Mr. Welch served as Vice President and Chief Financial Officer of Beluga Composites Corporation (formerly, Biocircuits Corp.) since July 1997. Mr. Welch joined Beluga Composites Corporation in 1992 and served as its Corporate Controller from June 1992 to February 1997, Secretary and Treasurer since June 1997. Mr. Welch served as an Independent Consultant at various companies from June 1998 to May 1999. Mr. Welch served as Division Controller at NeXT Computer Inc., From 1985 to 1988 he held various positions at Avantek Inc., a Telecommunications company, where his most recent position was a Senior Finance Manager. Mr. Welch holds an M.B.A. from Washington State University and a B.A. in Business Administration from Whitworth College.
